Benefit from Panakeia's diagnostic solutions or leverage our platform for your research
Panakeia is developing clinical products enabling biomarker profiling across various cancer types and other disease areas:
Receive accurate biomarker results in minutes, not days
Reduce material and admin costs compared to lab based testing
Integrates seamlessly with existing digital workflows
PANProfiler Breast (ER, PR, HER2)
Breast cancer diagnostic tool that reports tissue ER, PR, HER2 status by analysing H&E slides. Seamlessly integrates with existing digital workflows and reduces the need for time consuming lab tests, returning accurate results sooner to patients and multidisciplinary teams.
The device is available only in Great Britain (UKCA) and the EU (CE) as an IVD medical device. It is not yet available in the United States. Request documentation
Research & Drug Development
Take advantage of Panakeia’s leading platform for end-to-end-learning and explainable AI in histopathology. Utilize our special capabilities to read molecular biomarkers, or to discover novel signatures from H&E stained specimens.
Leverage Panakeia's proprietary H&E biomarker PANProfiler solutions
Add other stains or omics data and enrich the scope of your research
Complement your resources with our team’s dedicated expertise in AI, data science, pathology & translational medicine
Profit from our regulatory expertise in developing software as medical device
Use our network of clinical partners to expand your research opportunities or independently validate your own predictive biomarkers
Gain deeper insights, faster results & better decisions across:
Test your hypothesis, select the right indication, or understand mechanisms of action. Benefit from Panakeia's dedicated capabilities in diagnostic-grade explainable AI and data science.
Enable precision medicine: from signature discovery over validation of predictive biomarkers, to prospective testing for selecting the right patients in your clinical trials: Panakeia is your partner in advancing the clinical development of targeted therapies.
Benefit from our platform's end-to-end development capabilities for biomarker analytical and clinical validation. Quickly gather safety and efficacy evidence through our rapid experimentation and deployment abilities.